Lung Cancer Discovery Award
The Lung Cancer Discovery Award from the American Lung Association funds innovative research to advance the science of lung cancer understanding, diagnosis, prevention, and treatment.
Funder: American Lung Association
Due Dates: September 18, 2026 (Letter of Intent) | December 1, 2026 (Full Application)
Funding Amounts: $100,000/year for up to 2 years (maximum $200,000 total); no indirect costs allowed.
Summary: Supports innovative research to advance understanding, diagnosis, prevention, and treatment of lung cancer.
Key Information: LOI required; only one application per cycle; U.S. nonprofit institutions only.
Description
This award supports highly innovative, high-impact research projects that advance the understanding, diagnosis, prevention, or treatment of lung cancer. The program encourages pioneering work across a range of scientific areas, including basic biology, genetics, novel screening, and therapeutic strategies. The goal is to accelerate progress in lung cancer research and improve outcomes for patients. Projects may focus on new diagnostic or therapeutic paradigms, genetic forms of lung cancer, prevention strategies, or other transformative approaches.
